-
1
-
-
0034850405
-
Disorders of prolactin secretion
-
Molitch ME (2001) Disorders of prolactin secretion. Endocrinol Metab Clin North Am 30(3):585-610
-
(2001)
Endocrinol Metab Clin North Am
, vol.30
, Issue.3
, pp. 585-610
-
-
Molitch, M.E.1
-
2
-
-
0032961611
-
The pathology of pituitary tumors
-
Asa SL (1999) The pathology of pituitary tumors. Endocrinol Metab Clin North Am 28(1):13-vi
-
(1999)
Endocrinol Metab Clin North Am
, vol.28
, Issue.1
-
-
Asa, S.L.1
-
3
-
-
0031726012
-
Imaging of giant pituitary adenomas
-
Majos C, Coll S, Aguilera C, Acebes JJ, Pons LC (1998) Imaging of giant pituitary adenomas. Neuroradiology 40(10):651-655
-
(1998)
Neuroradiology
, vol.40
, Issue.10
, pp. 651-655
-
-
Majos, C.1
Coll, S.2
Aguilera, C.3
Acebes, J.J.4
Pons, L.C.5
-
4
-
-
0036328386
-
Giant prolactinomas: Clinical management and long-term follow up
-
Shrivastava RK, Arginteanu MS, King WA, Post KD (2002) Giant prolactinomas: Clinical management and long-term follow up. J Neurosurg 97(2):299-306
-
(2002)
J Neurosurg
, vol.97
, Issue.2
, pp. 299-306
-
-
Shrivastava, R.K.1
Arginteanu, M.S.2
King, W.A.3
Post, K.D.4
-
5
-
-
0032531231
-
Management of pituitary tumors
-
Shimon I, Melmed S (1998) Management of pituitary tumors. Ann Intern Med 129(6):472-483
-
(1998)
Ann Intern Med
, vol.129
, Issue.6
, pp. 472-483
-
-
Shimon, I.1
Melmed, S.2
-
6
-
-
0021347129
-
Rapid size reduction of giant prolactinoma following medical treatment
-
Perani D, Colombo N, Scotti G, Tonon C (1984) Rapid size reduction of giant prolactinoma following medical treatment. J Comput Assist Tomogr 8(1):131-133
-
(1984)
J Comput Assist Tomogr
, vol.8
, Issue.1
, pp. 131-133
-
-
Perani, D.1
Colombo, N.2
Scotti, G.3
Tonon, C.4
-
7
-
-
0030019740
-
High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas
-
St Jean E, Blain F, Comtois R (1996) High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas. Clin Endocrinol (Oxf) 44(3):305-309
-
(1996)
Clin Endocrinol (Oxf)
, vol.44
, Issue.3
, pp. 305-309
-
-
St Jean, E.1
Blain, F.2
Comtois, R.3
-
8
-
-
0031946789
-
Pituitary adenomas secreting large amounts of prolactin may give false low values in immunoradiometric assays. The hook effect
-
Petakov MS, Damjanovic SS, Nikolic-Durovic MM, et al (1998) Pituitary adenomas secreting large amounts of prolactin may give false low values in immunoradiometric assays. The hook effect. J Endocrinol Invest 21(3):184-188
-
(1998)
J Endocrinol Invest
, vol.21
, Issue.3
, pp. 184-188
-
-
Petakov, M.S.1
Damjanovic, S.S.2
Nikolic-Durovic, M.M.3
-
9
-
-
0034649388
-
Giant prolactinoma and hook effect
-
Pakzaban P (2000) Giant prolactinoma and hook effect. Neurology 55(9):1415-1416
-
(2000)
Neurology
, vol.55
, Issue.9
, pp. 1415-1416
-
-
Pakzaban, P.1
-
10
-
-
0026995742
-
Prolactinomas and resistance to dopamine agonists
-
Brue T, Pellegrini I, Priou A, Morange I, Jaquet P (1992) Prolactinomas and resistance to dopamine agonists. Horm Res 38(1-2):84-89
-
(1992)
Horm Res
, vol.38
, Issue.1-2
, pp. 84-89
-
-
Brue, T.1
Pellegrini, I.2
Priou, A.3
Morange, I.4
Jaquet, P.5
-
11
-
-
0031753687
-
Surgical indication after bromocriptine therapy on giant prolactinomas: Effects and limitations of the medical treatment
-
Saeki N, Nakamura M, Sunami K, Yamaura A (1998) Surgical indication after bromocriptine therapy on giant prolactinomas: Effects and limitations of the medical treatment. Endocr J 45(4):529-537
-
(1998)
Endocr J
, vol.45
, Issue.4
, pp. 529-537
-
-
Saeki, N.1
Nakamura, M.2
Sunami, K.3
Yamaura, A.4
-
12
-
-
0026742206
-
Dopamine agonists and pituitary tumor shrinkage
-
Bevan JS, Webster J, Burke CW, Scanlon MF (1992) Dopamine agonists and pituitary tumor shrinkage. Endocr Rev 13(2):220-240
-
(1992)
Endocr Rev
, vol.13
, Issue.2
, pp. 220-240
-
-
Bevan, J.S.1
Webster, J.2
Burke, C.W.3
Scanlon, M.F.4
-
13
-
-
0032964305
-
Medical treatment of prolactinomas
-
vii
-
Molitch ME (1999) Medical treatment of prolactinomas. Endocrinol Metab Clin North Am 28(1):143-69, vii
-
(1999)
Endocrinol Metab Clin North Am
, vol.28
, Issue.1
, pp. 143-169
-
-
Molitch, M.E.1
-
14
-
-
0036774377
-
The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma
-
Gillam MP, Middler S, Freed DJ, Molitch ME (2002) The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma. J Clin Endocrinol Metab 87(10):4447-4451
-
(2002)
J Clin Endocrinol Metab
, vol.87
, Issue.10
, pp. 4447-4451
-
-
Gillam, M.P.1
Middler, S.2
Freed, D.J.3
Molitch, M.E.4
-
15
-
-
0024799025
-
Long-term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinemia
-
Ciccarelli E, Miola C, Avataneo T, Camanni F, Besser GM, Grossman A (1989) Long-term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinemia. Fertil Steril 52(6):930-935
-
(1989)
Fertil Steril
, vol.52
, Issue.6
, pp. 930-935
-
-
Ciccarelli, E.1
Miola, C.2
Avataneo, T.3
Camanni, F.4
Besser, G.M.5
Grossman, A.6
-
16
-
-
0025272634
-
Giant invasive prolactinoma: A case report and review of nine further cases
-
Davis JR, Sheppard MC, Heath DA (1990) Giant invasive prolactinoma: A case report and review of nine further cases. Q J Med 74(275):227-238
-
(1990)
Q J Med
, vol.74
, Issue.275
, pp. 227-238
-
-
Davis, J.R.1
Sheppard, M.C.2
Heath, D.A.3
-
17
-
-
0026521043
-
Giant basal prolactinoma extending into the nasal cavity
-
Iwai Y, Hakuba A, Khosla VK, et al (1992) Giant basal prolactinoma extending into the nasal cavity. Surg Neurol 37(4):280-283
-
(1992)
Surg Neurol
, vol.37
, Issue.4
, pp. 280-283
-
-
Iwai, Y.1
Hakuba, A.2
Khosla, V.K.3
-
18
-
-
0026774787
-
Treatment of extensively invasive (giant) prolactinomas with bromocriptine
-
Grebe SK, Delahunt JW, Feek CM (1992) Treatment of extensively invasive (giant) prolactinomas with bromocriptine. N Z Med J 105(931):129-131
-
(1992)
N Z Med J
, vol.105
, Issue.931
, pp. 129-131
-
-
Grebe, S.K.1
Delahunt, J.W.2
Feek, C.M.3
-
19
-
-
0023106074
-
Testosterone-related exacerbation of a prolactin-producing macroadenoma: Possible role for estrogen
-
Prior JC, Cox TA, Fairholm D, Kostashuk E, Nugent R (1987) Testosterone-related exacerbation of a prolactin-producing macroadenoma: possible role for estrogen. J Clin Endocrinol Metab 64(2):391-394
-
(1987)
J Clin Endocrinol Metab
, vol.64
, Issue.2
, pp. 391-394
-
-
Prior, J.C.1
Cox, T.A.2
Fairholm, D.3
Kostashuk, E.4
Nugent, R.5
-
20
-
-
0034433114
-
Rapid re-expansion of a macroprolactinoma after early discontinuation of bromocriptine
-
Orrego JJ, Chandler WF, Barkan AL (2000) Rapid re-expansion of a macroprolactinoma after early discontinuation of bromocriptine. Pituitary 3(3):189-192
-
(2000)
Pituitary
, vol.3
, Issue.3
, pp. 189-192
-
-
Orrego, J.J.1
Chandler, W.F.2
Barkan, A.L.3
-
21
-
-
0031227802
-
Neurological picture. A "giant" prolactinoma
-
Reuter U, Mehraein S, Arnold G, Lehmann R (1997) Neurological picture. A "giant" prolactinoma. J Neurol Neurosurg Psychiatry 63(3):295
-
(1997)
J Neurol Neurosurg Psychiatry
, vol.63
, Issue.3
, pp. 295
-
-
Reuter, U.1
Mehraein, S.2
Arnold, G.3
Lehmann, R.4
-
22
-
-
0020080133
-
Bromocriptine in management of large pituitary tumours
-
Wass JA, Williams J, Charlesworth M, et al (1982) Bromocriptine in management of large pituitary tumours. Br Med J (Clin Res Ed) 284(6333):1908-1911
-
(1982)
Br Med J (Clin Res Ed)
, vol.284
, Issue.6333
, pp. 1908-1911
-
-
Wass, J.A.1
Williams, J.2
Charlesworth, M.3
-
23
-
-
0034578628
-
Pergolide as primary therapy for macroprolactinomas
-
Orrego JJ, Chandler WF, Barkan AL (2000) Pergolide as primary therapy for macroprolactinomas. Pituitary 3(4):251-256
-
(2000)
Pituitary
, vol.3
, Issue.4
, pp. 251-256
-
-
Orrego, J.J.1
Chandler, W.F.2
Barkan, A.L.3
-
24
-
-
0031969319
-
Giant pituitary prolactinoma with falsely low serum prolactin: The pitfall of the "high-dose hook effect": Case report
-
Barkan AL, Chandler WF (1998) Giant pituitary prolactinoma with falsely low serum prolactin: The pitfall of the "high-dose hook effect": Case report. Neurosurgery 42(4):913-915
-
(1998)
Neurosurgery
, vol.42
, Issue.4
, pp. 913-915
-
-
Barkan, A.L.1
Chandler, W.F.2
-
25
-
-
33644856097
-
Combined treatment of invasive giant prolactinomas
-
Yu C, Wu Z, Gong J (2005) Combined treatment of invasive giant prolactinomas. Pituitary 8:61-65
-
(2005)
Pituitary
, vol.8
, pp. 61-65
-
-
Yu, C.1
Wu, Z.2
Gong, J.3
-
26
-
-
33644518385
-
Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus: Results of a long-term follow up
-
Wu ZB, Yu CJ, Su ZP,Shuge QC, Wu JS, Zheng WM (2006) Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus: results of a long-term follow up. J Neurosurg 104:54-61
-
(2006)
J Neurosurg
, vol.104
, pp. 54-61
-
-
Wu, Z.B.1
Yu, C.J.2
Su, Z.P.3
Shuge, Q.C.4
Wu, J.S.5
Zheng, W.M.6
-
27
-
-
33644551298
-
Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men
-
Chattopadhyay A, Bhansali A, Masoodi SR (2005) Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men. Pituitary 8:147-154
-
(2005)
Pituitary
, vol.8
, pp. 147-154
-
-
Chattopadhyay, A.1
Bhansali, A.2
Masoodi, S.R.3
|